Langerhans-Cell Histiocytoses - Epidemiology, Classification, Clinical Features, Diagnosis, Complications, Treatment and Prognosis

1. Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ. Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol. 2012; 156(1): 163-72.10.1111/j.1365-2141.2011.08915.x22017623Search in Google Scholar

2. Hand A. General tuberculosis. Trans Pathol Soc Philadelphia. 1883;16:282.Search in Google Scholar

3. Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LjM, Arico M et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med PediatrOncol. 1997;29(3): 157-66.Search in Google Scholar

4. Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet. 1987;1:208-9.Search in Google Scholar

5. Oreshkov K Stoeva N. [How far we have come in understanding Langerhans histiocytosis]. Medinfo. 2008; 12:35-40. Bulgarian.Search in Google Scholar

6. Lynch JP. Rare interstitial lung diseases: pulmonary Langerhans cell histiocytosis, lymphangioleiomyomatosis, and cryptogenic organizing pneumonia. In: ACCP Pulmonary Medicine Board Review. 25th ed. Northbrook, IL: American College of Chest Physicians; 2009.10.1378/pmbr.25th.585Search in Google Scholar

7. Kissenpfennig A, A'l't-Yahia S, Clair-Moninot V, Stossel H, Badell E, Bordat Y, et al. Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol Cell Biol. 2005;25(l):88-99.10.1128/MCB.25.1.88-99.200553879115601833Search in Google Scholar

8. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 2007;7:19-30.10.1038/nri199617170756Search in Google Scholar

9. Berres ML, Merad M, Allen CE. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Br J Haematol. 2015; 169(1):3-13.10.1111/bjh.13247519322125430560Search in Google Scholar

10. Csire M, Mikala G, Jako J, Masszi T, Janosi J, Dolgos J. Persistent long-term human herpesvirus 6 (HHV-6) infection in a patient with langerhans cell histiocytosis. Pathol Oncol Res. 2007;13(2): 157-60.10.1007/BF0289349317607379Search in Google Scholar

11. Allen CE, Li L, Petere TL, Leung HC, Yu A, Man TK. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010; 184(8):4557-67.10.4049/jimmunol.0902336314267520220088Search in Google Scholar

12. Allen CE, McClain KL. Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions. Nat Med. 2009; 15(5 ):483-5.10.1038/nm0509-483282082819424201Search in Google Scholar

13. Bank MI, Gudbrand C, Rengtved P, Carstensen H, Fadeel B, Henter JI et al. Immunohistochemical detection of the apoptosis-related proteins FADD, FLICE, and FLIP in Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 2005;27(6):301 -6.10.1097/01.mph.0000168725.57143.5215956881Search in Google Scholar

14. da Costa CE, Szuhai K, van Eijk R, Hoogeboom M, Sciot R, Mertens F, et al. No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies. Genes Chromosomes Cancer. 2009;48(3):239-49.10.1002/gcc.2063419051326Search in Google Scholar

15. HarocheJ,CharlotteF,Amaud L, VonDeimlingA, Helias-Rodzewicz Z, Hervier B, et al. High prevalence of BRAF mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012; 120(13):2700-3.10.1182/blood-2012-05-430140Search in Google Scholar

16. Nelson DS, van Halteren A, Quispel WT, van den Bos C, Bovee JV, Patel B, et al. MAP2K1 and MAP3K1 mutations in langerhans cell histiocytosis. Genes Chromosomes Cancer. 2015;54(6):361 -8.10.1002/gcc.22247Search in Google Scholar

17. Satoh T, Smith A, Sarde A, Lu HC, Mian S, Trouillet C, et al. B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease. PLoS ONE 2012;7(4):e33891.10.1371/journal.pone.0033891Search in Google Scholar

18. Cerri S, Spagnolo P, Luppi F, Richeldi L. Smoking-related interstitial lung disease. In: Cordier JF, editor. Orphan Lung Diseases: Volume 54 of European Respiratory Monograph. Plymouth: European Respiratory Society; 2011.376 p.10.1183/1025448x.10008710Search in Google Scholar

19. Strenger V, Urban C. Chromosomal integration of the HHV-6 genome as a possible cause of persistent HHV-6 detection in a patient with langerhans cell histiocytosis. Pathol Oncol Res. 2010; 16(1): 125-6.10.1007/s12253-009-9197-2Search in Google Scholar

20. Ribeiro KB, Degar B, Antoneli CB, Rollins B, Rodriguez-Galindo C. Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2015 ;62(6);982-7.10.1002/pbc.25404Search in Google Scholar

21. Delobbe A, Durieu J, Duhamel A, Wallaert B, the Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). EurRespirJ. 1996;9:2002-6.10.1183/09031936.96.09102002Search in Google Scholar

22. Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T. Clinico epidemiological features of pulmonary histiocytosis X. Intern Med. 2001;40:998-1003.10.2169/internalmedicine.40.998Search in Google Scholar

23. Ivanov S. [Sarcoidosis and other granulomatoses], Sofia: Nasko-1701; 2000. Bulgarian.Search in Google Scholar

24. Gaensler E, Carrington C. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenograph!c, and physiological correlations in 502 patients. Ann Thorac Suig. 1980;30:411 -26.10.1016/S0003-4975(10)61291-XSearch in Google Scholar

25. Haupt R, Minkov M, Astigarraga I, Schafer E, Nanduri V, Jubran R, et al. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60(2): 175-84.10.1002/pbc.24367455704223109216Search in Google Scholar

26. Lampert F. Langerhans cell histiocytosis. Historical perspectives. Hematol Oncol Clin North Am. 1998; 12(2): 213 -9.Search in Google Scholar

27. Kluge G, Sorge I, Bierbach U, Hirsch W. Scapula as an uncommon site of Langerhans cell histiocytosis in an infant. Pediatr Int. 2010;52(1): 142-4.10.1111/j.1442-200X.2009.02944.xSearch in Google Scholar

28. Friedman PJ,Liebow A A, SokoloffJ. Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore). 1981;60:385-96.10.1097/00005792-198111000-00001Search in Google Scholar

29. Unger J, England D, Collins J. Miliary nodules, Hodgkin's disease, and eosinophilic granuloma. J Thorac Imaging. 1994;9:71-3.10.1097/00005382-199421000-00002Search in Google Scholar

30. Lahey ME. Prognosis in retinucloendotheliosis in children. J Pediatr. 1962;60:664-71.10.1016/S0022-3476(62)80091-2Search in Google Scholar

31. Arico M, Haupt R, Russotto VS, Bossi G, Scappaticci S, Danesino C. Langerhans cell histiocytosis in two generations: a new family and review of the literature. Med Pediatr Oncol. 2001;36:314-6.10.1002/1096-911X(20010201)36:2<314::AID-MPO1072>3.0.CO;2-1Search in Google Scholar

32. Marinova D, Titorenkov P, Slavova Y. [Pulmonary Langerhans Cell Histiocytosis]. Inspiro. 2013;4(24): 39-42. Bulgarian.Search in Google Scholar

33. Chaowalit N, Pellikka PA, Decker PA. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc. 2004;79:1269-75.10.4065/79.10.1269Search in Google Scholar

34. Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King TE Jr. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med. 1996;153:426-35.10.1164/ajrccm.153.1.8542154Search in Google Scholar

35. Fridlender ZG, Glazer M, Amir G, Berkman N. Obstructing tracheal pulmonary Langerhans cell histiocytosis. Chest. 2005; 128:1057-8.10.1378/chest.128.2.1057Search in Google Scholar

36. Sundar KM, Gosselin MV, Chung HL, Cahill BC. Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest. 2003;123:1673-83.10.1378/chest.123.5.1673Search in Google Scholar

37. Vassallo R, Ryu JH, Colby TV, Hartman T,Limper AH. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med. 2000;342:1969-78.10.1056/NEJM200006293422607Search in Google Scholar

38. Simko SJ, McClain KL, Allen CE. Up-front therapy for LCH: is it time to test an alternative to vinblastine/prednisone? Br J Haematol. 2015; 169(2):299-301.10.1111/bjh.13208Search in Google Scholar

39. Veys PA, Nanduri V, Baker KS, He W, Bandini G, Biondi A, et al. Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning. BrJ Haematol. 2015; 169(5):711-8.10.1111/bjh.13347Search in Google Scholar

40. Arico M, Astigarraga I, Braier J, Donadieu J, Gadner H, Glogova E, et al. Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood. Br J Haematol. 2015; 169(2):241 -8.10.1111/bjh.13271Search in Google Scholar

41. Egeler RM, Neglia JP, Puccetti DM, Brennan CA, Nesbit ME. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer. 1993;71:865-73.10.1002/1097-0142(19930201)71:3<865::AID-CNCR2820710334>3.0.CO;2-0Search in Google Scholar

42. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med. 2002;346:484-90.10.1056/NEJMoa012087Search in Google Scholar

43. Thomeer M, Demedts M, Vandeurzen K. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg. 2001;56:163-72. 10.1179/acb.2001.026Search in Google Scholar